Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 650-656

  Passamonti, Francesco ^a   Pietra, Daniela ^a   Malabarba, Lucia ^a   Rumi, Elisa ^a   Della Porta, Matteo Giovanni ^a   Malcovati, Luca ^a   Bonfichi, Maurizio ^a   Pascutto, Cristiana ^a   Lazzarino, Mario ^a   Cazzola, Mario ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

CD177; Chronic myeloproliferative disorder; Essential thrombocythaemia; Myelofibrosis with myeloid metaplasia; Polycythaemia vera; PRV 1

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTOSIS; FEMALE; GENE EXPRESSION; HUMAN; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; ISOANTIGENS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NEUTROPHILS; PHILADELPHIA CHROMOSOME; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 4544323963     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05098.x     Document Type: Article

References (32)

1. Barosi, G., Ambrosetti, A., Finelli, C., Grossi, A., Leoni, P., Liberato, N.L., Petti, M.C., Pogliani, E., Ricetti, M., Rupoli, S., Visani, G. & Tura, S. (1999) The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. British Journal of Haematology, 104, 730-737.
2. Barosi, G., Viarengo, G., Pecci, A., Rosti, V., Piaggio, G., Marchetti, M. & Frassoni, F. (2001) Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood, 98, 3249-3255.
3. Berlin, N.I. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 339-351.
4. Bettinotti, M.P., Olsen, A. & Stroncek, D. (2002) The use of bioinformatics to identify the genomic structure of the gene that encodes neutrophil antigen NB1, CD177. Clinical Immunology, 102, 138-144.
5. Bock, O., Serinsoz, E., Neusch, M., Schlue, J. & Kreipe, H. (2003) The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders. British Journal of Haematology, 123, 472-474.
6. Caruccio, L., Walkovich, K., Bettinotti, M., Schuller, R. & Stroncek, D. (2004) CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression. Transfusion, 44, 77-82.
7. Cilloni, D., Carturan, S., Gottardi, E., Messa, F., Fava, M., Defilippi, I., Arruga, F. & Saglio, G. (2004) Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients. Blood, 103, 2428.
8. Florensa, L., Besses, C., Zamora, L., Bellosillo, B., Espinet, B., Serrano, S., Woessner, S. & Sole, F. (2004) Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia. Blood, 103, 2427-2428.
9. Fruehauf, S., Topaly, J., Villalobos, M., Veldwijk, M.R., Laufs, S. & Ho, A.D. (2003) Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients. Haematologica, 88, 349-351.
10. Griesshammer, M., Klippel, S., Strunck, E., Temerinac, S., Mohr, U., Heimpel, H. & Pahl, H.L. (2004) PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Ann Hematol, 83, 364-370.
11. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) Pathology and Genetics of Tumours of the Haemopoietic and Lymphoid Tissues. WHO Classification of Tumours, Geneve.
12. Johansson, P., Andreasson, B., Safai-Kutti, S., Wennstrom, L., Palmqvist, L., Ricksten, A., Lindstedt, G. & Kutti, J. (2003) The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. European Journal of Haematology, 70, 358-362.
13. Klippel, S., Strunck, E., Temerinac, S., Bench, A.J., Meinhardt, G., Mohr, U., Leichtle, R., Green, A.R., Griesshammer, M., Heimpel, H. & Pahl, H.L. (2003) Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood, 102, 3569-3574.
14. Kralovics, R., Guan, Y. & Prchal, J.T. (2002) Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Experimental Hematology, 30, 229-236.
15. Kralovics, R., Buser, A.S., Teo, S.S., Coers, J., Tichelli, A., van der Maas, A.P. & Skoda, R.C. (2003) Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood, 102, 1869-1871.
16. Liu, E., Jelinek, J., Pastore, Y.D., Guan, Y., Prchal, J.F. & Prchal, J.T. (2003) Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood, 101, 3294-3301.
17. Messinezy, M., Westwood, N.B., El-Hemaidi, I., Marsden, J.T., Sherwood, R.S. & Pearson, T.C. (2002) Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. British Journal of Haematology, 117, 47-53.
18. Moliterno, A.R. & Spivak, J.L. (1999) Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood, 94, 2555-2561.
19. Moliterno, A.R., Hankins, W.D. & Spivak, J.L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New England Journal of Medicine, 338, 572-580.
20. Murphy, S., Iland, H., Rosenthal, D. & Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Hematology, 23, 177-182.
21. Murphy, S., Peterson, P., Iland, H. & Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 29-39.
22. Palmqvist, L., Goerttler, P., Wasslavik, C., Johansson, P., Andreasson, B., Safai-Kutti, S., Kutti, J., Pahl, H.L. & Ricksten, A. (2004) Comparison of methods for polycythemia rubra vera-1 mRNA quantification in whole-blood leukocytes and purified granulocytes. Clinical Chemistry, 50, 644-647.
23. Passamonti, F., Vanelli, L., Malabarba, L., Rumi, E., Pungolino, E., Malcovati, L., Pascutto, C., Morra, E., Lazzarino, M. & Cazzola, M. (2003) Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica, 88, 1123-1129.
24. Shih, L.Y. & Lee, C.T. (1994) Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood, 83, 744-748.
25. Spivak, J.L. (2002) Polycythemia vera: myths, mechanisms, and management. Blood, 100, 4272-4290.
26. Stroncek, D.F., Caruccio, L. & Bettinotti, M. (2004) CD177: A Member of the Ly-6 Gene Superfamily Involved with Neutrophil Proliferation and Polycythemia Vera. Journal of Translational Medicine, 2, 8.
27. Tefftri, A., Lasho, T.L., Wolanskyj, A.P. & Mesa, R.A. (2003) Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood, 103, 3547-3548.
28. Temerinac, S., Klippel, S., Strunck, E., Roder, S., Lubbert, M., Lange, W., Azemar, M., Meinhardt, G., Schaefer, H.E. & Pahl, H.L. (2000) Cloning of PRV-1 a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood, 95, 2569-2576.
29. Teofili, L. Martini, M., Luongo, M., Di Mario, A., Leone, G., De Stefano, V. & Larocca, L.M. (2002) Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. Journal of Clinical Oncology, 20, 4249-4254.
30. Wolff, J., Brendel, C., Fink, L., Bohle, R.M., Kissel, K. & Bux, J. (2003) Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP-neutrophils from NB1 GP-expressing individuals and association of low expression with NB1 gene polymorphisms. Blood, 102, 731-733.
31. Zhang, J., Pellagatti, A., Campbell, L., Eagleton, H., Gal, S., Fidler, C., Boultwood, J. & Wainscoat, J.S. (2004) Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders [abstract]. British Journal of Haematology, 125, 53.
32. Zwicky, C., Theiler, L., Zbaren, K., Ischi, E. & Tobler, A. (2002) The predictive value of clonogenic stem cell assays for the diagnosis of polycythaemia vera. British Journal of Haematology, 117, 598-604.